Skip to main content
Top
Published in: Endocrine 3/2018

01-03-2018 | Original Article

LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer

Authors: Yuan Qin, Wei Sun, Hao Zhang, Ping Zhang, Zhihong Wang, Wenwu Dong, Liang He, Ting Zhang, Liang Shao, Wenqian Zhang, Changhao Wu

Published in: Endocrine | Issue 3/2018

Login to get access

Abstract

Purpose

The long non-coding RNA GAS8 antisense RNA 1 (lncRNA GAS8-AS1) is a tumor suppressor in papillary thyroid cancer (PTC), but the mechanisms underlying how GAS8-AS1 regulates PTC biology remain unclear. Here, we evaluated the molecular function of GAS8-AS1 in regulating autophagy in PTC cell lines.

Methods

GAS8-AS1 was overexpressed and knocked down in PTC cell lines by transfecting with expression plasmids or short interfering RNAs (siRNAs). Cell proliferation was evaluated using the Cell Counting Kit-8 (CCK-8). qRT-PCR and western blot were used to determine changes in expression of autophagy-related genes. Autophagy was evaluated by immunofluorescence and transmission electron microscopy.

Results

Relative GAS8-AS1 expression was lower in the PTC cell lines, TPC1 and BCPAP, compared to a normal thyroid cell line. Overexpression of GAS8-AS1 inhibited proliferation, significantly increased the ratio of LC3-II/LC3-I, and reduced p62 expression, whereas GAS8-AS1 knockdown demonstrated opposite effects. In GAS8-AS1 overexpressing cell lines, LC3 immunofluorescence staining demonstrated increased punctate aggregates of LC3 staining, and transmission electron microscopy revealed increased numbers of autophagosomes. Autophagy-related gene 5 (ATG5) was markedly upregulated by GAS8-AS1 overexpression and downregulated by GAS8-AS1 knockdown. Finally, silencing of ATG5 attenuated autophagy activation and rescued the inhibition of cell proliferation caused by GAS8-AS1.

Conclusions

In PTC cell lines, GAS8-AS1 inhibited proliferation, activated autophagy, and increased ATG5 expression. Downregulation of ATG5 reversed GAS8-AS1-mediated activation of autophagy leading to cell death, revealing a novel mechanism of the GAS8-AS1-ATG5 axis in PTC cell lines. This provided a new experimental basis to explore the effects of lncRNA on autophagy in the treatment of thyroid cancer.
Literature
1.
go back to reference G. Pellegriti, F. Frasca, C. Regalbuto, S. Squatrito, R. Vigneri, Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J. Cancer Epidemiol. 2013, 965212 (2013)CrossRef G. Pellegriti, F. Frasca, C. Regalbuto, S. Squatrito, R. Vigneri, Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J. Cancer Epidemiol. 2013, 965212 (2013)CrossRef
2.
go back to reference O. Gimm, M.D. Castellone, C. Hoang-Vu, E. Kebebew, Biomarkers in thyroid tumor research: new diagnostic tools and potential targets of molecular-based therapy. J. Thyroid. Res. 2011, 631593 (2011)CrossRef O. Gimm, M.D. Castellone, C. Hoang-Vu, E. Kebebew, Biomarkers in thyroid tumor research: new diagnostic tools and potential targets of molecular-based therapy. J. Thyroid. Res. 2011, 631593 (2011)CrossRef
3.
go back to reference R.W. Randle et al., Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017)CrossRef R.W. Randle et al., Trends in the presentation, treatment, and survival of patients with medullary thyroid cancer over the past 30 years. Surgery 161, 137–146 (2017)CrossRef
4.
go back to reference D.F. Schneider, H. Chen, New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J. Clin. 63, 374–394 (2013)CrossRef D.F. Schneider, H. Chen, New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J. Clin. 63, 374–394 (2013)CrossRef
5.
go back to reference L. Lamartina, et al., Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer. J. Clin. Endocrinol. Metab 101, 3036–3044 (2016)CrossRef L. Lamartina, et al., Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer. J. Clin. Endocrinol. Metab 101, 3036–3044 (2016)CrossRef
6.
go back to reference C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12, 646–653 (2016)CrossRef C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12, 646–653 (2016)CrossRef
7.
go back to reference C.K. Chou, R.T. Liu, H.Y. Kang, MicroRNA-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer. Int. J. Mol. Sci. 18, E636 (2017)CrossRef C.K. Chou, R.T. Liu, H.Y. Kang, MicroRNA-146b: a novel biomarker and therapeutic target for human papillary thyroid cancer. Int. J. Mol. Sci. 18, E636 (2017)CrossRef
8.
go back to reference B.R. Haugen et al., 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRef B.R. Haugen et al., 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26, 1–133 (2016)CrossRef
9.
go back to reference J.T. Lee, Epigenetic regulation by long noncoding RNAs. Science 338, 1435–1439 (2012)CrossRef J.T. Lee, Epigenetic regulation by long noncoding RNAs. Science 338, 1435–1439 (2012)CrossRef
10.
go back to reference J.L. Rinn, H.Y. Chang, Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145–166 (2012)CrossRef J.L. Rinn, H.Y. Chang, Genome regulation by long noncoding RNAs. Annu. Rev. Biochem. 81, 145–166 (2012)CrossRef
11.
go back to reference J. Zhao, Y. Liu, G. Huang, P. Cui, W. Zhang, Y. Zhang, Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am. J. Cancer Res.. 5, 907–927 (2015)PubMedPubMedCentral J. Zhao, Y. Liu, G. Huang, P. Cui, W. Zhang, Y. Zhang, Long non-coding RNAs in gastric cancer: versatile mechanisms and potential for clinical translation. Am. J. Cancer Res.. 5, 907–927 (2015)PubMedPubMedCentral
12.
go back to reference J. Sun et al., Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. Mol. Biosyst. 10, 2074–2081 (2014)CrossRef J. Sun et al., Inferring novel lncRNA-disease associations based on a random walk model of a lncRNA functional similarity network. Mol. Biosyst. 10, 2074–2081 (2014)CrossRef
13.
go back to reference R. Fatima, V.S. Akhade, D. Pal, S.M. Rao, Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol. Cell. Ther. 3, 5 (2015)CrossRef R. Fatima, V.S. Akhade, D. Pal, S.M. Rao, Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets. Mol. Cell. Ther. 3, 5 (2015)CrossRef
14.
go back to reference M. Zhou et al., Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol. Biosyst. 11, 760–769 (2015)CrossRef M. Zhou et al., Prioritizing candidate disease-related long non-coding RNAs by walking on the heterogeneous lncRNA and disease network. Mol. Biosyst. 11, 760–769 (2015)CrossRef
15.
go back to reference M. Zhou et al., A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. J. Transl. Med. 13, 231 (2015)CrossRef M. Zhou et al., A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer. J. Transl. Med. 13, 231 (2015)CrossRef
16.
go back to reference M. Zhou et al., Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer. Oncotarget 7, 32433–32448 (2016)PubMedPubMedCentral M. Zhou et al., Comprehensive analysis of lncRNA expression profiles reveals a novel lncRNA signature to discriminate nonequivalent outcomes in patients with ovarian cancer. Oncotarget 7, 32433–32448 (2016)PubMedPubMedCentral
17.
go back to reference M. Zhou et al., Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. J. Exp. Clin. Cancer Res. 34, 102 (2015)CrossRef M. Zhou et al., Identification and validation of potential prognostic lncRNA biomarkers for predicting survival in patients with multiple myeloma. J. Exp. Clin. Cancer Res. 34, 102 (2015)CrossRef
18.
go back to reference H. Cai et al., LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Oncotarget 8, 32905–32917 (2017)PubMedPubMedCentral H. Cai et al., LncRNA HOTAIR acts a competing endogenous RNA to control the expression of notch3 via sponging miR-613 in pancreatic cancer. Oncotarget 8, 32905–32917 (2017)PubMedPubMedCentral
19.
go back to reference L. Fang, et al., Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB. Am. J. Physiol. Gastrointest. Liver Physiol 313, G150–G156 (2017)CrossRef L. Fang, et al., Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB. Am. J. Physiol. Gastrointest. Liver Physiol 313, G150–G156 (2017)CrossRef
20.
go back to reference W. Zhou et al., The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci. Signal 10, eaak9557 (2017)CrossRef W. Zhou et al., The lncRNA H19 mediates breast cancer cell plasticity during EMT and MET plasticity by differentially sponging miR-200b/c and let-7b. Sci. Signal 10, eaak9557 (2017)CrossRef
21.
go back to reference P.D. Li et al., Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1. Oncotarget 8, 34164–34176 (2017)PubMedPubMedCentral P.D. Li et al., Upregulation of the long non-coding RNA PVT1 promotes esophageal squamous cell carcinoma progression by acting as a molecular sponge of miR-203 and LASP1. Oncotarget 8, 34164–34176 (2017)PubMedPubMedCentral
22.
go back to reference M. Yang et al., Long noncoding RNA are aberrantly expressed in human papillary thyroid carcinoma. Oncol. Lett. 12, 544–552 (2016)CrossRef M. Yang et al., Long noncoding RNA are aberrantly expressed in human papillary thyroid carcinoma. Oncol. Lett. 12, 544–552 (2016)CrossRef
23.
go back to reference W. Pan et al., Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Hum. Mol. Genet. 25, 1875–1884 (2016)CrossRef W. Pan et al., Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Hum. Mol. Genet. 25, 1875–1884 (2016)CrossRef
24.
go back to reference A.M. Choi, S.W. Ryter, B. Levine, Autophagy in human health and disease. N. Engl. J. Med. 368, 651–662 (2013)CrossRef A.M. Choi, S.W. Ryter, B. Levine, Autophagy in human health and disease. N. Engl. J. Med. 368, 651–662 (2013)CrossRef
25.
go back to reference K. Wang et al., APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun. 6, 6779 (2015)CrossRef K. Wang et al., APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat. Commun. 6, 6779 (2015)CrossRef
26.
go back to reference Q.W. Fan et al., Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci. Signal 3, ra81 (2010)CrossRef Q.W. Fan et al., Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci. Signal 3, ra81 (2010)CrossRef
27.
go back to reference J.S. Carew et al., Cleveland, The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib. Cancer Res. 68, 4783–4790 (2008)CrossRef J.S. Carew et al., Cleveland, The novel polyamine analogue CGC-11093 enhances the antimyeloma activity of bortezomib. Cancer Res. 68, 4783–4790 (2008)CrossRef
28.
go back to reference Z.J. Yang, C.E. Chee, S. Huang, F.A. Sinicrope, The role of autophagy in cancer: therapeutic implications. Mol. Cancer Ther. 10, 1533–1541 (2011)CrossRef Z.J. Yang, C.E. Chee, S. Huang, F.A. Sinicrope, The role of autophagy in cancer: therapeutic implications. Mol. Cancer Ther. 10, 1533–1541 (2011)CrossRef
29.
go back to reference B.P. Rubin, J. Debnath, Therapeutic implications of autophagy-mediated cell survival in gastrointestinal stromal tumor after treatment with imatinib mesylate. Autophagy 6, 1190–1191 (2010)CrossRef B.P. Rubin, J. Debnath, Therapeutic implications of autophagy-mediated cell survival in gastrointestinal stromal tumor after treatment with imatinib mesylate. Autophagy 6, 1190–1191 (2010)CrossRef
30.
go back to reference D.J. Klionsky et al., Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1–222 (2016)CrossRef D.J. Klionsky et al., Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12, 1–222 (2016)CrossRef
31.
go back to reference J. Lin et al., Inhibition of autophagy enhances the anticancer activity of silver nanoparticles. Autophagy 10, 2006–2020 (2014)CrossRef J. Lin et al., Inhibition of autophagy enhances the anticancer activity of silver nanoparticles. Autophagy 10, 2006–2020 (2014)CrossRef
32.
go back to reference T.R. Mercer, M.E. Dinger, J.S. Mattick, Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10, 155–159 (2009)CrossRef T.R. Mercer, M.E. Dinger, J.S. Mattick, Long non-coding RNAs: insights into functions. Nat. Rev. Genet. 10, 155–159 (2009)CrossRef
33.
go back to reference J. Liz, M. Esteller, lncRNAs and microRNAs with a role in cancer development. Biochim. Biophys. Acta 1859, 169–176 (2016)CrossRef J. Liz, M. Esteller, lncRNAs and microRNAs with a role in cancer development. Biochim. Biophys. Acta 1859, 169–176 (2016)CrossRef
34.
go back to reference H. Li, B. Yu, J. Li, L. Su, M. Yan, Z. Zhu, B. Liu, Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 5, 2318–2329 (2014)PubMedPubMedCentral H. Li, B. Yu, J. Li, L. Su, M. Yan, Z. Zhu, B. Liu, Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget 5, 2318–2329 (2014)PubMedPubMedCentral
35.
go back to reference T. Nakagawa et al., Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem. Biophys. Res. Commun. 436, 319–324 (2013)CrossRef T. Nakagawa et al., Large noncoding RNA HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer. Biochem. Biophys. Res. Commun. 436, 319–324 (2013)CrossRef
36.
go back to reference W. Sun et al., Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer. Med. Oncol. 33, 102 (2016)CrossRef W. Sun et al., Overexpression of long non-coding RNA NR_036575.1 contributes to the proliferation and migration of papillary thyroid cancer. Med. Oncol. 33, 102 (2016)CrossRef
37.
go back to reference X. Lan et al., Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Tumour Biol. 37, 6117–6123 (2016)CrossRef X. Lan et al., Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance. Tumour Biol. 37, 6117–6123 (2016)CrossRef
38.
go back to reference D. Zhang, X. Liu, B. Wei, G. Qiao, T. Jiang, Z. Chen, Plasma lncRNA GAS8-AS1 as a potential biomarker of papillary thyroid carcinoma in Chinese patients. Int. J. Endocrinol. 2017, 2645904 (2017)PubMedPubMedCentral D. Zhang, X. Liu, B. Wei, G. Qiao, T. Jiang, Z. Chen, Plasma lncRNA GAS8-AS1 as a potential biomarker of papillary thyroid carcinoma in Chinese patients. Int. J. Endocrinol. 2017, 2645904 (2017)PubMedPubMedCentral
39.
go back to reference F. Scarlatti, R. Granata, A.J. Meijer, P. Codogno, Does autophagy have a license to kill mammalian cells. Cell. Death Differ. 16, 12–20 (2009)CrossRef F. Scarlatti, R. Granata, A.J. Meijer, P. Codogno, Does autophagy have a license to kill mammalian cells. Cell. Death Differ. 16, 12–20 (2009)CrossRef
40.
go back to reference M. Gugnoni et al., Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy. Oncogene 36, 667–677 (2017)CrossRef M. Gugnoni et al., Cadherin-6 promotes EMT and cancer metastasis by restraining autophagy. Oncogene 36, 667–677 (2017)CrossRef
41.
go back to reference M. Hamada, H. Kameyama, S. Iwai, Y. Yura, Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells. Cell. Death Discov. 3, 17047 (2017)CrossRef M. Hamada, H. Kameyama, S. Iwai, Y. Yura, Induction of autophagy by sphingosine kinase 1 inhibitor PF-543 in head and neck squamous cell carcinoma cells. Cell. Death Discov. 3, 17047 (2017)CrossRef
42.
go back to reference D.J. Klionsky et al., Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151–175 (2008)CrossRef D.J. Klionsky et al., Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151–175 (2008)CrossRef
43.
go back to reference N. Mizushima, T. Yoshimori, B. Levine, Methods in mammalian autophagy research. Cell 140, 313–326 (2010)CrossRef N. Mizushima, T. Yoshimori, B. Levine, Methods in mammalian autophagy research. Cell 140, 313–326 (2010)CrossRef
44.
go back to reference Y.L. Xiu et al., Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. Oncotarget 8, 31714–31725 (2017)PubMedPubMedCentral Y.L. Xiu et al., Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3. Oncotarget 8, 31714–31725 (2017)PubMedPubMedCentral
45.
go back to reference L. Yu et al., Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500–1502 (2004)CrossRef L. Yu et al., Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 304, 1500–1502 (2004)CrossRef
46.
go back to reference S. Shimizu et al., Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell. Biol. 6, 1221–1228 (2004)CrossRef S. Shimizu et al., Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell. Biol. 6, 1221–1228 (2004)CrossRef
Metadata
Title
LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer
Authors
Yuan Qin
Wei Sun
Hao Zhang
Ping Zhang
Zhihong Wang
Wenwu Dong
Liang He
Ting Zhang
Liang Shao
Wenqian Zhang
Changhao Wu
Publication date
01-03-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1520-1

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.